木曜日, 4月 24, 0020

20080423 EMEA Reflection Paper on Benefit-Risk assessment methods in the context of evaluation of Marketing Authorisation application of medicinal

23/04/08
Reflection Paper on Benefit-Risk assessment methods in the context of evaluation of Marketing Authorisation application of medicinal products for human use

0 件のコメント: